| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.6M | — |
| Cost of Revenue | $4.0M | — |
| Gross Profit | $1.5M | — |
| R&D Expense | $91K | — |
| SG&A Expense | $6.3M | +249.4% |
| Operating Income | -$17.0M | -846.9% |
| Interest Expense | $117K | — |
| Pre-tax Income | -$32.0M | -1682.9% |
| Income Tax | -$13K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | +319.9% |
| Accounts Receivable | $67K | — |
| Inventory | $1.3M | — |
| Current Assets | $6.1M | +298.9% |
| Total Assets | $16.1M | +953.2% |
| Current Liabilities | $934K | +715.5% |
| Total Liabilities | $1.3M | +1026.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.0M | -81.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$853K | — |
| Financing Cash Flow | $7.7M | +1914.8% |
| Free Cash Flow | -$4.0M | -81.3% |
| Net Income | -$32.0M | -1682.2% |
| EPS (Basic) | -$3.84 | -433.3% |
| EPS (Diluted) | -$3.84 | -611.1% |
| Stockholders' Equity |
| $14.8M |
| +947.3% |